Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S. Leuchter AF, et al. Among authors: marangell lb. Psychiatry Res. 2009 Sep 30;169(2):132-8. doi: 10.1016/j.psychres.2009.04.004. Epub 2009 Aug 26. Psychiatry Res. 2009. PMID: 19709754 Clinical Trial.
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study.
Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S. Leuchter AF, et al. Among authors: marangell lb. Psychiatry Res. 2009 Sep 30;169(2):124-31. doi: 10.1016/j.psychres.2009.06.004. Epub 2009 Aug 27. Psychiatry Res. 2009. PMID: 19712979
Relationship between major depressive disorder and associated painful physical symptoms: analysis of data from two pooled placebo-controlled, randomized studies of duloxetine.
Robinson MJ, Sheehan D, Gaynor PJ, Marangell LB, Tanaka Y, Lipsius S, Ohara F, Namiki C. Robinson MJ, et al. Among authors: marangell lb. Int Clin Psychopharmacol. 2013 Nov;28(6):330-8. doi: 10.1097/YIC.0b013e328364381b. Int Clin Psychopharmacol. 2013. PMID: 23873291 Clinical Trial.
Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol.
Oakes TM, Myers AL, Marangell LB, Ahl J, Prakash A, Thase ME, Kornstein SG. Oakes TM, et al. Among authors: marangell lb. Hum Psychopharmacol. 2012 Jan;27(1):47-56. doi: 10.1002/hup.1262. Epub 2012 Jan 13. Hum Psychopharmacol. 2012. PMID: 22241678 Clinical Trial.
A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
Ball S, Dellva MA, D'Souza DN, Marangell LB, Russell JM, Goldberger C. Ball S, et al. Among authors: marangell lb. J Affect Disord. 2014;167:215-23. doi: 10.1016/j.jad.2014.06.006. Epub 2014 Jun 14. J Affect Disord. 2014. PMID: 24995890 Clinical Trial.
122 results